Delivery Order SPE2DB22D2214-SPE2DB24FS3KD
Award Date
2/2/24
Potential Completion Date
2/5/24
Potential Value
$5.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $18,165.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DALIRESP 500 MCG TABLET 90S, a pharmaceutical product. The award has a completion date of September 9, 2022 and was issued on a firm fixed-price basis. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides delivery orders for the pharmaceutical product Daliresp 500 mcg tablet. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order valued at $3,777.63 with a period of performance through November 3, 2023. The contract does not have a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This federal contract award, valued at $3,196.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DALIRESP 500 MCG TABLET 30S, a pharmaceutical product. This is a delivery order contract with a firm fixed price. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Daliresp 250 mcg tablets to the Defense Logistics Agency (DLA). The $2,671.64 firm-fixed-price delivery order is the latest in a series of contracts between Amerisourcebergen and the DLA, with the company holding a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of DALIRESP 500 MCG TABLET 90S. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a ceiling value of $20,496.82 and was placed as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of...
This federal contract award is for the delivery of DALIRESP 250 MCG TABLETS to the Defense Logistics Agency (DLA). The $7,094.02 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of February 8, 2024 and was awarded on February 7, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $77,176.71 firm-fixed-price delivery order is for the pharmaceutical product Daliresp 500 mcg tablets. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is a delivery order (SPE2DB20D3505|SPE2DB24FT2W2) worth $1,099.55 to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is from the Defense Logistics Agency (DLA) for the pharmaceutical product DALIRESP 500 MCG TABLET 30S. The contract has an ultimate completion date of October 25, 2023 and is a firm fixed price agreement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,579.64 Firm Fixed Price Delivery Order covers the supply of DALIRESP 500 MCG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, with ID SPE2DB20D2014|SPE2DB23FC11R, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,256.66 fixed-price delivery order is for the supply of DALIRESP 500 MCG TABLET 90S, a pharmaceutical product, with a performance period through May 3, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...